TEL AVIV, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced upcoming scientific presentations at the Gordon Research Conference on Chemotactic Cytokines and at EASL 2024, the Annual Congress of the European Association for the Study of the Liver. Gordon Research Conference: Chemotactic Cytokines - Portland, Maine, USA, June 2-7, 2024
recruitment of hepatic stellate cells, monocytes and neutrophils and modulates hepatic stellate cell activationPresenter:Prof. Amnon Peled, Hadassah University Hospital; Faculty of Medicine, Hebrew UniversityInformation:2024 Chemotactic Cytokines Conference GRC EASL Congress 2024 – Milan, Italy, June 5-8, 2024
Date:June 6, 2024Time:8:30-18:00 CESTFormat:Poster presentation: Ex-vivo translational assay of hepatic stellate cells using patient- derived serum characterizes the anti-fibrotic activity of CM-101Presenter:Revital Aricha, PhD, Vice President, Translational Science, Chemomab TherapeuticsSession:Poster - Fibrosis/Stellate cell biology, Abstract #380 Date:June 6, 2024Time:8:30-17:00 CESTFormat:Poster presentation: Machine learning-driven identification of serum protein signature for primary sclerosing cholangitis and enhanced liver fibrosis scorePresenter: Ilan Vaknin, PhD, Vice President, R&D, Chemomab TherapeuticsSession:Immune-mediated and cholestatic: Experimental and pathophysiology, Abstract #1032 Date:June 7, 2024Time:12:25-13:45 CESTFormat:Poster Tour: Ex-vivo translational assay of hepatic stellate cells using patient-derived serum characterizes the anti-fibrotic activity of CM-101Presenter:Ilan Vaknin, PhD, Vice President, R&D, Chemomab TherapeuticsSession:Fibrosis/Stellate Cell Biology Poster Tour, Abstract #380Location:Basic Science Track HubInformation:EASL Congress 2024 In addition, Chemomab Corporate Development will be in San Diego June 3-6, 2024, participating in the BIO International Convention’s One-on-One Partnering™ event. Registered attendees can click here to log in and schedule a meeting with Chemomab.
Consulting Vice President
Investor & Public Relations,
barbara.lindheim@chemomab.com